Global Hydroxyprogesterone Caproate Injection Market Will Reach to $ US$ 263.3 Million in 2027 - QYResearch Report

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication. AMAG Pharmaceuticals is the leading manufacturer worldwide with the revenue market share of 83%, followed by Mcguff Pharmaceuticals Inc, Aspen Oss B.V, American Regent, Inc., and Mylan Institutional. North America and Europe are the two biggest selling regions, with the combined sales market share of 72%. In the forecast period, Asia-Pacific is expected to see the rapidest development. The global Hydroxyprogesterone Caproate Injection market size is projected to reach US$ 287.9 million by 2027, from US$ 263.3 million in 2020, at a CAGR of 1.5% during 2021-2027.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/2792376/global-hydroxyprogesterone-caproate-injection-industry

In terms of production side, this report researches the Hydroxyprogesterone Caproate Injection production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type. In terms of consumption side, this report focuses on the consumption of Hydroxyprogesterone Caproate Injection by regions (countries) and by Application. The global Hydroxyprogesterone Caproate Injection market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Hydroxyprogesterone Caproate Injection market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period. Geographic Segmentation The report offers exhaustive assessment of different region-wise Hydroxyprogesterone Caproate Injection markets such as North America., etc.

Key regions covered in the report are

U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Hydroxyprogesterone Caproate Injection market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume. Manufacturers The report includes comprehensive company profiling of leading and emerging companies competing in the global Hydroxyprogesterone Caproate Injection market. It provides a detailed list of players operating at a global level.

The players have been listed according to the type of products they offer in the global Hydroxyprogesterone Caproate Injection market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021. By Type and Application Segments The report includes a detailed analysis of leading and type and application segments of the global Hydroxyprogesterone Caproate Injection market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Hydroxyprogesterone Caproate Injection market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Hydroxyprogesterone Caproate Injection market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Hydroxyprogesterone Caproate Injection market by each application segment for the same period. This report includes the following manufacturers:, AMAG Pharmaceuticals, Mcguff Pharmaceuticals Inc, Aspen Oss B.V, American Regent, Inc., Mylan Institutional

Market Segment by Type

, 1 mL Injection, 5 mL Injection, The 5 mL Injection accounted for a larger market share of 52% in 2018, but it was projected to be exceeded by the 1mL one in 2025. Market Segment by Application, Hospitals Injection, Clinics Injection, Hospital took a larger market share of 51% in 2018, but it was expected to be exceeded by the Clinic in 2025. Research Methodology To compile the detailed study of the global Hydroxyprogesterone Caproate Injection market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Hydroxyprogesterone Caproate Injection market. QY Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Hydroxyprogesterone Caproate Injection market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.

Request Customization of Report @ https://www.qyresearch.com/customize-request/form/2792376/global-hydroxyprogesterone-caproate-injection-industry

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Type
1.2.2 1 mL Injection
1.2.3 5 mL Injection
1.3 Market Segment by Application
1.3.1 Global Hydroxyprogesterone Caproate Injection Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Hospitals Injection
1.3.3 Clinics Injection
1.4 Study Objectives
1.5 Years Considered 2 Market Perspective
2.1 Global Hydroxyprogesterone Caproate Injection Market Size (2016-2027)
2.1.1 Global Hydroxyprogesterone Caproate Injection Revenue (2016-2027)
2.1.2 Global Hydroxyprogesterone Caproate Injection Sales (2016-2027)
2.2 Global Hydroxyprogesterone Caproate Injection Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Regions (2016-2021)
2.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Regions (2016-2021)
2.3 Global Hydroxyprogesterone Caproate Injection Market Size Forecast by Region
2.3.1 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Region (2022-2027)
2.3.2 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Region (2022-2027)
2.4 Global Top Hydroxyprogesterone Caproate Injection Regions (Countries) Ranking by Market Size
2.5 Hydroxyprogesterone Caproate Injection Industry Trends
2.5.1 Hydroxyprogesterone Caproate Injection Market Trends
2.5.2 Hydroxyprogesterone Caproate Injection Market Drivers
2.5.3 Hydroxyprogesterone Caproate Injection Market Challenges
2.5.4 Hydroxyprogesterone Caproate Injection Market Restraints 3 Competitive Landscape by Manufacturers
3.1 Global Top Hydroxyprogesterone Caproate Injection Manufacturers by Sales (2016-2021)
3.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Manufacturers (2016-2021)
3.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Hydroxyprogesterone Caproate Injection Sales in 2020
3.2 Global Top Manufacturers Hydroxyprogesterone Caproate Injection by Revenue
3.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Manufacturers (2016-2021)
3.2.2 Top Hydroxyprogesterone Caproate Injection Manufacturers Covered: Ranking by Revenue
3.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hydroxyprogesterone Caproate Injection Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hydroxyprogesterone Caproate Injection as of 2020)
3.4 Global Hydroxyprogesterone Caproate Injection Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Hydroxyprogesterone Caproate Injection Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Hydroxyprogesterone Caproate Injection Market
3.7 Key Manufacturers Hydroxyprogesterone Caproate Injection Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Hydroxyprogesterone Caproate Injection Market Size by Type
4.1 Global Hydroxyprogesterone Caproate Injection Historic Market Review by Type (2016-2021)
4.1.1 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2016-2021)
4.1.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2016-2021)
4.1.3 Hydroxyprogesterone Caproate Injection Price by Type (2016-2021)
4.2 Global Hydroxyprogesterone Caproate Injection Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Type (2022-2027)
4.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Type (2022-2027)
4.2.3 Hydroxyprogesterone Caproate Injection Price Forecast by Type (2022-2027) 5 Global Hydroxyprogesterone Caproate Injection Market Size by Application
5.1 Global Hydroxyprogesterone Caproate Injection Historic Market Review by Application (2016-2021)
5.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2016-2021)
5.1.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2016-2021)
5.1.4 Hydroxyprogesterone Caproate Injection Price by Application (2016-2021)
5.2 Global Hydroxyprogesterone Caproate Injection Market Estimates and Forecasts by Application (2022-2027)
5.2.2 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Application (2022-2027)
5.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Application (2022-2027)
5.2.4 Hydroxyprogesterone Caproate Injection Price Forecast by Application (2022-2027) 6 North America
6.1 North America Hydroxyprogesterone Caproate Injection Sales Breakdown by Company
6.1.1 North America Hydroxyprogesterone Caproate Injection Sales by Company (2016-2027)
6.1.2 North America Hydroxyprogesterone Caproate Injection Revenue by Company (2016-2027)
6.2 North America Hydroxyprogesterone Caproate Injection Market Size by Type (2016-2027)
6.2.1 North America Hydroxyprogesterone Caproate Injection Sales by Type (2016-2027)
6.2.2 North America Hydroxyprogesterone Caproate Injection Revenue by Type (2016-2027)
6.3 North America Hydroxyprogesterone Caproate Injection Market Size by Application (2016-2027)
6.3.1 North America Hydroxyprogesterone Caproate Injection Sales by Application (2016-2027)
6.3.2 North America Hydroxyprogesterone Caproate Injection Revenue by Application (2016-2027)
6.4 North America Hydroxyprogesterone Caproate Injection Market Size by Country
6.4.1 North America Hydroxyprogesterone Caproate Injection Sales by Country (2016-2027)
6.4.2 North America Hydroxyprogesterone Caproate Injection Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Hydroxyprogesterone Caproate Injection Sales Breakdown by Company
7.1.1 Europe Hydroxyprogesterone Caproate Injection Sales by Company (2016-2027)
7.1.2 Europe Hydroxyprogesterone Caproate Injection Revenue by Company (2016-2027)
7.2 Europe Hydroxyprogesterone Caproate Injection Market Size by Type (2016-2027)
7.2.1 Europe Hydroxyprogesterone Caproate Injection Sales by Type (2016-2027)
7.2.2 Europe Hydroxyprogesterone Caproate Injection Revenue by Type (2016-2027)
7.3 Europe Hydroxyprogesterone Caproate Injection Market Size by Application (2016-2027)
7.3.1 Europe Hydroxyprogesterone Caproate Injection Sales by Application (2016-2027)
7.3.2 Europe Hydroxyprogesterone Caproate Injection Revenue by Application (2016-2027)
7.4 Europe Hydroxyprogesterone Caproate Injection Market Size by Country
7.4.1 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2016-2027)
7.4.2 Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia 8 Asia Pacific
8.1 Asia Pacific Hydroxyprogesterone Caproate Injection Sales Breakdown by Company
8.1.1 Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Company (2016-2027)
8.1.2 Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Company (2016-2027)
8.2 Asia Pacific Hydroxyprogesterone Caproate Injection Market Size by Type (2016-2027)
8.2.1 Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Type (2016-2027)
8.2.2 Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Type (2016-2027)
8.3 Asia Pacific Hydroxyprogesterone Caproate Injection Market Size by Application (2016-2027)
8.3.1 Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Application (2016-2027)
8.3.2 Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Application (2016-2027)
8.4 Asia Pacific Hydroxyprogesterone Caproate Injection Market Size by Regions
8.4.1 Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Regions
8.4.2 Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam 9 Latin America
9.1 Latin America Hydroxyprogesterone Caproate Injection Sales Breakdown by Company
9.1.1 Latin America Hydroxyprogesterone Caproate Injection Sales by Company (2016-2027)
9.1.2 Latin America Hydroxyprogesterone Caproate Injection Revenue by Company (2016-2027)
9.2 Latin America Hydroxyprogesterone Caproate Injection Market Size by Type (2016-2027)
9.2.1 Latin America Hydroxyprogesterone Caproate Injection Sales by Type (2016-2027)
9.2.2 Latin America Hydroxyprogesterone Caproate Injection Revenue by Type (2016-2027)
9.3 Latin America Hydroxyprogesterone Caproate Injection Market Size by Application (2016-2027)
9.3.1 Latin America Hydroxyprogesterone Caproate Injection Sales by Application (2016-2027)
9.3.2 Latin America Hydroxyprogesterone Caproate Injection Revenue by Application (2016-2027)
9.4 Latin America Hydroxyprogesterone Caproate Injection Market Size by Country
9.4.1 Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2016-2027)
9.4.2 Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina 10 Middle East and Africa
10.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Breakdown by Company
10.1.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Company (2016-2027)
10.1.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Company (2016-2027)
10.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Type (2016-2027)
10.2.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Type (2016-2027)
10.3 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Application (2016-2027)
10.3.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Application (2016-2027)
10.4 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size by Country
10.4.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2016-2027)
10.4.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E 11 Company Profiles
11.1 AMAG Pharmaceuticals
11.1.1 AMAG Pharmaceuticals Corporation Information
11.1.2 AMAG Pharmaceuticals Overview
11.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Products and Services
11.1.5 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection SWOT Analysis
11.1.6 AMAG Pharmaceuticals Recent Developments
11.2 Mcguff Pharmaceuticals Inc
11.2.1 Mcguff Pharmaceuticals Inc Corporation Information
11.2.2 Mcguff Pharmaceuticals Inc Overview
11.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Products and Services
11.2.5 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection SWOT Analysis
11.2.6 Mcguff Pharmaceuticals Inc Recent Developments
11.3 Aspen Oss B.V
11.3.1 Aspen Oss B.V Corporation Information
11.3.2 Aspen Oss B.V Overview
11.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Products and Services
11.3.5 Aspen Oss B.V Hydroxyprogesterone Caproate Injection SWOT Analysis
11.3.6 Aspen Oss B.V Recent Developments
11.4 American Regent, Inc.
11.4.1 American Regent, Inc. Corporation Information
11.4.2 American Regent, Inc. Overview
11.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Products and Services
11.4.5 American Regent, Inc. Hydroxyprogesterone Caproate Injection SWOT Analysis
11.4.6 American Regent, Inc. Recent Developments
11.5 Mylan Institutional
11.5.1 Mylan Institutional Corporation Information
11.5.2 Mylan Institutional Overview
11.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Products and Services
11.5.5 Mylan Institutional Hydroxyprogesterone Caproate Injection SWOT Analysis
11.5.6 Mylan Institutional Recent Developments 12 Value Chain and Sales Channels Analysis
12.1 Hydroxyprogesterone Caproate Injection Value Chain Analysis
12.2 Hydroxyprogesterone Caproate Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hydroxyprogesterone Caproate Injection Production Mode & Process
12.4 Hydroxyprogesterone Caproate Injection Sales and Marketing
12.4.1 Hydroxyprogesterone Caproate Injection Sales Channels
12.4.2 Hydroxyprogesterone Caproate Injection Distributors
12.5 Hydroxyprogesterone Caproate Injection Customers 13 Research Findings and Conclusion 14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Why to Buy this Report?

Exhaustive analysis of business strategies of top players in the global Hydroxyprogesterone Caproate Injection market, the value chain, raw materials, and industry variables
Easy to understand, to-the-point data, statistics, and information on the global Hydroxyprogesterone Caproate Injection market, its segments, and sub-segments
Deep research on distribution channels and the distribution chain including retailers, wholesalers, manufacturers, dealers, suppliers, and consumers
Thorough evaluation of key regional Hydroxyprogesterone Caproate Injection markets based on CAGR, supply and demand, macroeconomic patterns, customer purchasing patterns, and several other factors
Accurate and comprehensive study of the global Hydroxyprogesterone Caproate Injection market with the help of SWOT analysis, PESTLE analysis, and opportunity assessment
The report is a perfect example of a detailed and meticulously prepared research study on the global Hydroxyprogesterone Caproate Injection market. It can be customized as per the requirements of the client. It not only caters to market players but also stakeholders and key decision makers looking for extensive research and analysis on the global Hydroxyprogesterone Caproate Injection market.

Get Full Report In Your Inbox Within 24 Hours at USD(5600): https://www.qyresearch.com/settlement/pre/017db3432aaf2361ec1f8bfdde3bc399,0,1,global-hydroxyprogesterone-caproate-injection-industry

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

This release was published on openPR.